Single-Cell Transcriptomics of Mtb/HIV Co-Infection

Area of Science:

• Immunology
• Genomics
• Infectious Diseases

Background:

• Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection presents a major global health challenge.
• HIV co-infection exacerbates TB, increasing risks of latent TB infection (LTBI) reactivation, severe disease, and mortality.
• Current diagnostic methods lack biomarkers to differentiate active TB from LTBI or predict TB reactivation in co-infected individuals.

Purpose of the Study:

• To review the application of single-cell RNA sequencing (scRNA-seq) in dissecting the immune landscape of TB and HIV co-infection.
• To explore host-pathogen interactions and cellular heterogeneity in TB/HIV pathogenesis using scRNA-seq.
• To discuss the translational potential of scRNA-seq for improved TB/HIV diagnosis and management.

Main Methods:

• Review of studies utilizing single-cell RNA sequencing (scRNA-seq) to analyze immune responses in TB and HIV infections.
• Analysis of host-pathogen interactions and cellular heterogeneity at a single-cell level.
• Examination of animal models used in TB/HIV research and the utility of scRNA-seq in these models.

Main Results:

• scRNA-seq provides high-resolution insights into immune cell heterogeneity and function in TB and HIV infections.
• It facilitates the identification of distinct cellular signatures associated with single versus co-infections.
• scRNA-seq aids in understanding complex host-pathogen interactions and pathogenesis pathways.

Conclusions:

• scRNA-seq is a powerful tool for mapping the immune atlas in TB and HIV co-infection, revealing previously unrecognized cellular heterogeneity.
• This technology holds promise for identifying novel biomarkers for LTBI reactivation and predicting disease outcomes.
• Translational applications of scRNA-seq can significantly enhance diagnostic capabilities and therapeutic strategies for TB/HIV patients.